US6566368B2
(en)
*
|
1994-04-22 |
2003-05-20 |
Pentech Pharmaceuticals, Inc. |
Apomorphine-containing dosage form for ameliorating male erectile dysfunction
|
US5990168A
(en)
|
1996-04-18 |
1999-11-23 |
Alberta Cancer Board |
Methods and compositions for the treatment of ataxia telangiectasia
|
US7214686B2
(en)
*
|
1997-06-30 |
2007-05-08 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
US6908631B1
(en)
*
|
1997-12-01 |
2005-06-21 |
Nicogen, Inc. |
Therapeutic and diagnostic methods dependent on CYP2A enzymes
|
US6953855B2
(en)
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
US6432975B1
(en)
|
1998-12-11 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
DE69930552T2
(de)
|
1998-12-16 |
2006-11-30 |
University Of South Florida, Tampa |
Exo-s-mecamylamin-formulierung und ihre verwendung in behandlungen
|
FR2804430B1
(fr)
|
2000-01-28 |
2002-03-22 |
Sanofi Synthelabo |
Derives de 4-heteroaryl-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique
|
GB0010955D0
(en)
|
2000-05-05 |
2000-06-28 |
Novartis Ag |
Organic compounds
|
AR036041A1
(es)
*
|
2001-06-12 |
2004-08-04 |
Upjohn Co |
Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
|
DE10156719A1
(de)
|
2001-11-19 |
2003-05-28 |
Bayer Ag |
Heteroarylcarbonsäureamide
|
GB0128996D0
(en)
|
2001-12-04 |
2002-01-23 |
Novartis Ag |
Organic compounds
|
DE10211415A1
(de)
|
2002-03-15 |
2003-09-25 |
Bayer Ag |
Bicyclische N-Biarylamide
|
DE10211416A1
(de)
|
2002-03-15 |
2003-09-25 |
Bayer Ag |
Essig- und Propionsäureamide
|
SE0201943D0
(sv)
|
2002-06-20 |
2002-06-20 |
Astrazeneca Ab |
New use
|
DE10234424A1
(de)
|
2002-07-29 |
2004-02-12 |
Bayer Ag |
Benzothiophen-, Benzofuran- und Indolharnstoffe
|
US20050245567A1
(en)
|
2002-08-14 |
2005-11-03 |
Dan Peters |
Novel quinuclidine derivatives and their use
|
EP1531820A1
(en)
|
2002-08-30 |
2005-05-25 |
Memory Pharmaceuticals Corporation |
Anabaseine derivatives useful in the treatment of neurodegenerative diseases
|
GB0220581D0
(en)
*
|
2002-09-04 |
2002-10-09 |
Novartis Ag |
Organic Compound
|
PL210065B1
(pl)
|
2002-09-25 |
2011-11-30 |
Memory Pharm Corp |
Związki indazole, benzotiazole i benzoizotiazole, kompozycje farmaceutyczne je zawierające oraz zastosowanie związków
|
CA2515948A1
(en)
|
2003-02-14 |
2004-09-02 |
Memory Pharmaceuticals Corporation |
Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof
|
NZ540998A
(en)
|
2003-02-27 |
2008-06-30 |
Neurosearch As |
Novel diazabicyclic aryl derivatives
|
US20050065178A1
(en)
|
2003-09-19 |
2005-03-24 |
Anwer Basha |
Substituted diazabicycloakane derivatives
|
WO2005044267A1
(en)
|
2003-10-31 |
2005-05-19 |
Astrazeneca Ab |
Alkynes ii
|
EP1677788A1
(en)
|
2003-10-31 |
2006-07-12 |
AstraZeneca AB |
Alkynes iii
|
CA2549967A1
(en)
|
2003-10-31 |
2005-05-19 |
Astrazeneca Ab |
Alkynes i
|
FR2862647B1
(fr)
|
2003-11-25 |
2008-07-04 |
Aventis Pharma Sa |
Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
|
US20050245531A1
(en)
|
2003-12-22 |
2005-11-03 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
DE602004010299T2
(de)
|
2003-12-22 |
2008-09-18 |
Memory Pharmaceuticals Corp. |
Indole, 1h-indazole, 1,2-benzisoxazole und 1,2-benzisothiazole und deren herstellung und anwendungen
|
BRPI0506890A
(pt)
|
2004-02-04 |
2007-07-17 |
Neurosearch As |
derivado de arila diazabicìclica, composição farmacêutica, uso de um derivado de arila diazabicìclica, e, método de tratamento, prevenção ou alìvio de uma doença, distúrbio ou condição de um corpo de animal vivo
|
CN100432075C
(zh)
|
2004-02-04 |
2008-11-12 |
神经研究公司 |
作为烟碱样乙酰胆碱受体配体的二氮杂双环芳基衍生物
|
WO2005079802A1
(en)
|
2004-02-12 |
2005-09-01 |
Merck & Co., Inc. |
Bipyridyl amides as modulators of metabotropic glutamate receptor-5
|
AU2005227324A1
(en)
|
2004-03-25 |
2005-10-06 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
EP1742944B1
(en)
|
2004-04-22 |
2010-11-10 |
Memory Pharmaceuticals Corporation |
Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
|
NZ551712A
(en)
|
2004-05-07 |
2010-07-30 |
Memory Pharm Corp |
1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparations and uses thereof
|
EP1751150A2
(en)
|
2004-05-19 |
2007-02-14 |
Neurosearch A/S |
Novel azabicyclic aryl derivatives
|
GB0412019D0
(en)
|
2004-05-28 |
2004-06-30 |
Novartis Ag |
Organic compounds
|
AR049401A1
(es)
|
2004-06-18 |
2006-07-26 |
Novartis Ag |
Aza-biciclononanos
|
GB0415746D0
(en)
|
2004-07-14 |
2004-08-18 |
Novartis Ag |
Organic compounds
|
EP1802616B1
(en)
|
2004-10-15 |
2011-01-12 |
NeuroSearch A/S |
Novel azabicyclic aryl derivatives and their medical use
|
GB0424564D0
(en)
*
|
2004-11-05 |
2004-12-08 |
Novartis Ag |
Organic compounds
|
WO2006051407A1
(en)
|
2004-11-15 |
2006-05-18 |
Pfizer Products Inc. |
Azabenzoxazoles for the treatment of cns disorders
|
WO2006051394A1
(en)
*
|
2004-11-15 |
2006-05-18 |
Pfizer Products Inc. |
Azabenzoxazoles for the treatment of cns disorders
|
WO2006058879A1
(en)
|
2004-11-30 |
2006-06-08 |
Neurosearch A/S |
Novel diazabicyclic aryl derivatives as cholinergy ligands
|
JP2008523058A
(ja)
|
2004-12-10 |
2008-07-03 |
アボット・ラボラトリーズ |
縮合ビシクロ複素環置換キヌクリジン誘導体
|
AU2005319248A1
(en)
|
2004-12-22 |
2006-06-29 |
Memory Pharmaceuticals Corporation |
Nicotinic alpha-7 receptor ligands and preparation and uses thereof
|
US20060142349A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Pfizer Inc |
Methods of modulating the activities of alpha-7 nicotinic acetylcholine receptor
|
JP2008530172A
(ja)
|
2005-02-16 |
2008-08-07 |
ノイロサーチ アクティーゼルスカブ |
ジアザ二環系アリール誘導体及びそれらのニコチン様アセチルコリン受容体におけるコリン作動性リガンドとしての使用
|
CA2602348C
(en)
|
2005-03-31 |
2011-03-01 |
Pfizer Products Inc. |
Cyclopentapyridine and tetrahydroquinoline derivatives
|
US7585629B2
(en)
|
2005-04-22 |
2009-09-08 |
Cedars-Sinai Medical Center |
Compositions and methods for spinocerebellar ataxia
|
FR2884822B1
(fr)
|
2005-04-22 |
2007-06-29 |
Aventis Pharma Sa |
Derives de triazines, leur preparation et leur application en therapeutique
|
GB0508319D0
(en)
|
2005-04-25 |
2005-06-01 |
Novartis Ag |
Organic compounds
|
US8629163B2
(en)
|
2007-10-31 |
2014-01-14 |
University Of Kentucky Research Foundation |
Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptors
|
SG165417A1
(en)
|
2005-09-23 |
2010-10-28 |
Memory Pharm Corp |
Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
|
GB0521508D0
(en)
|
2005-10-21 |
2005-11-30 |
Novartis Ag |
Organic compounds
|
BRPI0619672A2
(pt)
|
2005-11-09 |
2011-10-11 |
Memory Pharm Corp |
composto, composição farmacêutica, e, uso de um composto
|
ATE473978T1
(de)
|
2005-12-06 |
2010-07-15 |
Neurosearch As |
Neue diazabicyclische arylderivate und medizinische verwendung dafür
|
GB0525672D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
GB0525673D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
CA2627630A1
(en)
|
2005-12-20 |
2007-06-28 |
Novartis Ag |
Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
|
US7662965B2
(en)
|
2006-01-26 |
2010-02-16 |
Cornerstone Therapeutics, Inc. |
Anabaseine derivatives, pharmaceutical compositions and method of use thereof
|
WO2007085036A1
(en)
|
2006-01-26 |
2007-08-02 |
Medizinische Universität Wien |
Treatment of friedreich' s ataxia
|
AU2007216531A1
(en)
|
2006-02-14 |
2007-08-23 |
Neurosearch A/S |
Novel diazabicycloalkane derivatives and their medical use
|
CA2637531A1
(en)
|
2006-02-17 |
2007-08-30 |
Memory Pharmaceuticals Corporation |
Compounds having 5-ht6 receptor affinity
|
UA95099C2
(ru)
|
2006-02-22 |
2011-07-11 |
Арнольд Мунних |
Применение деферипрона при лечении железо-индуцированного повреждения митохондрий, который является следствием атаксии фридрейха
|
KR20090005305A
(ko)
|
2006-03-27 |
2009-01-13 |
화이자 프로덕츠 인크. |
바레니클린 표준물질 및 불순물 제어
|
TW200813067A
(en)
|
2006-05-17 |
2008-03-16 |
Astrazeneca Ab |
Nicotinic acetylcholine receptor ligands
|
JP2009537599A
(ja)
|
2006-05-23 |
2009-10-29 |
ノイロサーチ アクティーゼルスカブ |
新規8,10−ジアザ−ビシクロ[4.3.1]デカン誘導体及びそれらの医学的使用
|
DE602007005255D1
(de)
|
2006-05-23 |
2010-04-22 |
Neurosearch As |
Neuartige 1,4-diazabicycloä3.2.2ünonan-derivate und deren medizinische verwendung
|
MX2008014887A
(es)
|
2006-05-30 |
2008-12-05 |
Neurosearch As |
Nuevos derivados de 1,4-diaza-biciclo[3.2.2]nonil oxadiazolilo y su uso medico.
|
AU2007267176A1
(en)
|
2006-05-30 |
2007-12-06 |
Neurosearch A/S |
Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives and their medical use
|
WO2007146066A2
(en)
|
2006-06-06 |
2007-12-21 |
Critical Therapeutics, Inc. |
Novel piperazines, pharmaceutical compositions and methods of use thereof
|
WO2007149163A2
(en)
|
2006-06-16 |
2007-12-27 |
University Of Kentucky |
Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
|
CA2657640A1
(en)
|
2006-07-14 |
2008-01-24 |
Pfizer Products Inc. |
Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2-methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine
|
US8314119B2
(en)
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
TW200901974A
(en)
|
2007-01-16 |
2009-01-16 |
Wyeth Corp |
Compounds, compositions, and methods of making and using them
|
MX2009008324A
(es)
|
2007-02-16 |
2009-10-20 |
Memory Pharm Corp |
Compuestos 6´-sustituidos que tienen afinidad con el receptor de 5-hidroxitriptamina-6.
|
GB2448224B
(en)
*
|
2007-04-02 |
2010-09-01 |
Parkinson S Inst |
Solid orally administered pharmaceutical composition for the reduction of side-effects of a dopaminergic agent
|
JP2010528037A
(ja)
|
2007-05-24 |
2010-08-19 |
メモリー・ファーマシューティカルズ・コーポレイション |
5−ht6受容体親和性を有する4’置換化合物
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
US20090069337A1
(en)
|
2007-08-15 |
2009-03-12 |
Memory Pharmaceuticals Corporation |
3' substituted compounds having 5-ht6 receptor affinity
|
US8114891B2
(en)
|
2007-10-01 |
2012-02-14 |
Comentis, Inc. |
4-substituted quinuclidine derivatives, methods of production, pharmaceutical uses thereof
|
JP5362729B2
(ja)
|
2007-10-04 |
2013-12-11 |
エフ.ホフマン−ラ ロシュ アーゲー |
シクロプロピルアリールアミド誘導体及びその使用
|
CA2701214C
(en)
|
2007-10-04 |
2016-08-02 |
F. Hoffmann-La Roche Ag |
Tetrazole-substituted aryl amide derivatives and uses thereof
|
WO2009066107A1
(en)
|
2007-11-21 |
2009-05-28 |
Astrazeneca Ab |
Use of a nicotinic receptor agonist
|
CA2714232A1
(en)
|
2008-02-05 |
2009-08-13 |
Pfizer Inc. |
Pyridinyl amides for the treatment of cns and metabolic disorders
|
ES2757648T3
(es)
|
2008-02-19 |
2020-04-29 |
Myocept Inc |
Agentes de quimiodenervación dirigida postsinápticamente y sus procedimientos de uso
|
US9463190B2
(en)
|
2008-03-31 |
2016-10-11 |
University Of South Florida |
Methods of treating disease-induced ataxia and non-ataxic imbalance
|
ES2392795T3
(es)
|
2008-04-17 |
2012-12-13 |
Proximagen Limited |
Indoles como moduladores del receptor nicotínico de acetilcolina de subtipo alfa-7
|
WO2009128058A1
(en)
|
2008-04-18 |
2009-10-22 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al |
Psycho-pharmaceuticals
|
WO2009143019A2
(en)
|
2008-05-23 |
2009-11-26 |
University Of South Florida |
Method of treating peripheral nerve sensory loss using compounds having nicotinic acetylcholine receptor activity
|
US20100016297A1
(en)
|
2008-06-24 |
2010-01-21 |
Memory Pharmaceuticals Corporation |
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
|
US20100022581A1
(en)
|
2008-07-02 |
2010-01-28 |
Memory Pharmaceuticals Corporation |
Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity
|
US20100029629A1
(en)
|
2008-07-25 |
2010-02-04 |
Memory Pharmaceuticals Corporation |
Acyclic compounds having 5-ht6 receptor affinity
|
US20100056531A1
(en)
|
2008-08-22 |
2010-03-04 |
Memory Pharmaceuticals Corporation |
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
|
US20100056491A1
(en)
|
2008-08-29 |
2010-03-04 |
Memory Pharmaceuticals Corporation |
4'-amino cyclic compounds having 5-ht6 receptor affinity
|
MX2011003429A
(es)
|
2008-10-13 |
2011-05-02 |
Hoffmann La Roche |
Metodo libre de diazonio para fabricar un compuesto intermedio de indazol en la sintesis de las amidas del acido 5-(trifluorometoxi)-1h-3-indazolcarboxilico biciclico.
|
WO2010056622A1
(en)
|
2008-11-11 |
2010-05-20 |
Targacept, Inc. |
TREATMENT WITH ALPHA α7-SELECTIVE LIGANDS
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
CN102802630A
(zh)
|
2009-06-17 |
2012-11-28 |
塔加西普特公司 |
通过神经元烟碱受体配体逆转左旋多巴诱导的运动障碍
|
EP2456438A2
(en)
|
2009-07-23 |
2012-05-30 |
Novartis AG |
Use of azabicycloalkyl derivatives or pyrrolidine-2-one derivatives
|
TWI558398B
(zh)
*
|
2009-09-22 |
2016-11-21 |
諾華公司 |
菸鹼乙醯膽鹼受體α7活化劑之用途
|